Publications

Sort by: Date | Author | Title

Petravic, J., Rasmussen, T. A., Lewin, S. R., Kent, S. J. & Davenport, M. P. (2017). Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents. Journal of Virology, 91(9), Article e02092-16. https://doi.org/10.1128/JVI.02092-16
Gane, E. J., Pianko, S., Roberts, S. K., Thompson, A. J., Zeuzem, S., Zuckerman, E., Ben-Ari, Z., Foster, G. R., Agarwal, K., Laursen, A. L., Gerstoft, J., Gao, W., Huang, H.-C., Fitzgerald, B., Fernsler, D., Li, J. J., Grandhi, A., Liu, H., Su, F.-H. ... Esteban, R. (2017). Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials. The Lancet Gastroenterology and Hepatology, 2(11), 805-813. https://doi.org/10.1016/S2468-1253(17)30159-0
Larsen, C. S. (2017). Sekundære immundefekter. In C. K. Holm (Ed.), Immunologi (1 ed., Vol. 1). FADL's Forlag.